Elicio Therapeutics, Inc. — All Filings
354 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001601485-25-000012 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001601485-25-000014 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | FORM 4 | 0001601485-25-000016 | Feb 4, 2025 | Feb 3, 2025 |
| 8-K | 8-K | 0001193125-25-016455 | Jan 30, 2025 | Jan 29, 2025 |
| 424B5 | 424B5 | 0001193125-25-016368 | Jan 30, 2025 | — |
| 8-K | 8-K | 0001601485-25-000009 | Jan 23, 2025 | — |
| 8-K | 8-K | 0001601485-25-000006 | Jan 22, 2025 | — |
| SCHEDULE 13G | — | 0000950170-25-002866 | Jan 7, 2025 | — |
| 4/A | FORM 4/A | 0001601485-25-000002 | Jan 2, 2025 | Jun 28, 2024 |
| 4 | FORM 4 | 0001601485-24-000109 | Dec 18, 2024 | Dec 16, 2024 |
| 8-K | 8-K | 0001601485-24-000107 | Dec 12, 2024 | — |
| 8-K | 8-K | 0001193125-24-269400 | Dec 3, 2024 | — |
| 4 | FORM 4 | 0001601485-24-000105 | Nov 29, 2024 | Nov 26, 2024 |
| 4 | FORM 4 | 0001601485-24-000101 | Nov 25, 2024 | Nov 21, 2024 |
| 4 | FORM 4 | 0001601485-24-000099 | Nov 25, 2024 | Nov 21, 2024 |
| 4 | FORM 4 | 0001601485-24-000089 | Nov 25, 2024 | Nov 21, 2024 |
| 4 | FORM 4 | 0001601485-24-000093 | Nov 25, 2024 | Nov 21, 2024 |
| 4 | FORM 4 | 0001601485-24-000091 | Nov 25, 2024 | Nov 21, 2024 |
| 4 | FORM 4 | 0001601485-24-000095 | Nov 25, 2024 | Nov 21, 2024 |
| 4 | FORM 4 | 0001601485-24-000097 | Nov 25, 2024 | Nov 21, 2024 |
| 424B3 | 424B3 | 0001601485-24-000087 | Nov 22, 2024 | — |
| 8-K | 8-K | 0001601485-24-000083 | Nov 21, 2024 | — |
| EFFECT | — | 9999999995-24-003532 | Nov 20, 2024 | — |
| CORRESP | — | 0001601485-24-000081 | Nov 18, 2024 | — |
| UPLOAD | — | 0000000000-24-012681 | Nov 15, 2024 | — |
| S-3 | S-3 | 0001601485-24-000078 | Nov 13, 2024 | — |
| 8-K | 8-K | 0001601485-24-000074 | Nov 13, 2024 | — |
| 10-Q | 10-Q | 0001601485-24-000075 | Nov 13, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001601485-24-000067 | Nov 7, 2024 | — |
| 8-K | 8-K | 0001601485-24-000063 | Nov 7, 2024 | — |
| 8-K | 8-K | 0001601485-24-000057 | Oct 17, 2024 | Oct 15, 2024 |
| 4 | FORM 4 | 0001601485-24-000049 | Oct 2, 2024 | Sep 30, 2024 |
| 4 | FORM 4 | 0001601485-24-000051 | Oct 2, 2024 | Sep 30, 2024 |
| 4 | FORM 4 | 0001601485-24-000053 | Oct 2, 2024 | Sep 30, 2024 |
| ARS | ARS | 0001140361-24-042211 | Sep 27, 2024 | Dec 31, 2023 |
| DEF 14A | DEF 14A | 0001140361-24-042209 | Sep 27, 2024 | Nov 7, 2024 |
| PRE 14A | PRE 14A | 0001140361-24-041303 | Sep 17, 2024 | Nov 7, 2024 |
| 8-K | 8-K | 0001140361-24-039592 | Aug 30, 2024 | Aug 27, 2024 |
| 4 | FORM 4 | 0001140361-24-037346 | Aug 14, 2024 | Aug 12, 2024 |
| SC 13D/A | GKCC, LLC ELICIO THERAPEUTICS, INC. SCHEDULE 13D/A | 0001068238-24-000167 | Aug 14, 2024 | — |
| 8-K | 8-K | 0001601485-24-000042 | Aug 13, 2024 | — |
| 10-Q | 10-Q | 0001601485-24-000045 | Aug 13, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0001140361-24-036848 | Aug 12, 2024 | — |
| 4 | FORM 4 | 0001140361-24-032293 | Jul 2, 2024 | Jun 28, 2024 |
| 4 | FORM 4 | 0001140361-24-032163 | Jul 2, 2024 | Jun 28, 2024 |
| SC 13D/A | GKCC, LLC ELICIO THERAPEUTICS, INC SCHEDULE 13D/A | 0001068238-24-000141 | Jul 2, 2024 | — |
| 8-K | FORM 8-K | 0001140361-24-031811 | Jul 1, 2024 | Jun 28, 2024 |
| 424B5 | 424B5 | 0001140361-24-031819 | Jul 1, 2024 | — |
| 8-K | 8-K | 0001140361-24-031563 | Jun 27, 2024 | — |
| 424B5 | 424B5 | 0001140361-24-031588 | Jun 27, 2024 | — |